Cannabinoid-based medicine Epidiolex approved for sale in Canada
Canada's federal health regulator has approved Jazz Pharmaceuticals Canada's cannabinoid-based medicine Epidiolex as an adjunctive therapy for certain…
News November 30Canada's federal health regulator has approved Jazz Pharmaceuticals Canada's cannabinoid-based medicine Epidiolex as an adjunctive therapy for certain…
News November 30Insurance reimbursements for medical cannabinoid products in Germany continued to grow in the first quarter of 2023, showing…
News August 17Insurance reimbursements for medical cannabis in Germany continue to reach fresh quarterly records, according to new data for…
News June 19Doctors in New Zealand no longer require Ministry of Health approval to prescribe Sativex, according to a new…
News April 9The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another.
News January 30A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana.
News January 13Insurance reimbursements for medical cannabis in Germany reached a new high during the July-September period, according to recently published data by…
News December 18New British guidelines for the first time recommend that two plant-based cannabis medicines – Sativex and Epidiolex –…
News November 12Brazil could become the latest country to regulate the domestic cultivation of medical cannabis, according to the government…
News June 17